Anticholinergic discontinuation for antipsychotic-induced extra-pyramidal symptoms
dc.contributor.author | Albert, Michael | |
dc.date.accessioned | 2017-09-20T15:57:30Z | |
dc.date.available | 2017-09-20T15:57:30Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Pereira, S. R. & Albert, M. (2017). Anticholinergic discontinuation for antipsychotic-induced extra-pyramidal symptoms. Cochrane Database of Systematic Reviews, -(3), pp.14. | |
dc.identifier.other | 10.1002/14651858.CD012525 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12904/9804 | |
dc.description.abstract | This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: | |
dc.description.abstract | To assess the effects of discontinuation compared with continued use of anticholinergic drugs prescribed for antipsychotic-induced extrapyramidal symptoms in people with schizophrenia and related disorders including schizophreniform disorder, delusional disorder, psychosis and schizoaffective disorder. | |
dc.description.uri | http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD012525/full | |
dc.format | Full text uploaded | |
dc.subject | Schizophrenia | |
dc.subject | Drug therapy | |
dc.title | Anticholinergic discontinuation for antipsychotic-induced extra-pyramidal symptoms | |
dc.type | Article | |
refterms.dateFOA | 2021-06-14T11:07:46Z | |
html.description.abstract | This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: | |
html.description.abstract | To assess the effects of discontinuation compared with continued use of anticholinergic drugs prescribed for antipsychotic-induced extrapyramidal symptoms in people with schizophrenia and related disorders including schizophreniform disorder, delusional disorder, psychosis and schizoaffective disorder. |